Status:
COMPLETED
Clinical Evaluation of Modified 2.2mm Microincision Phacoemulsification for Age-related Cataract
Lead Sponsor:
Zhongshan Ophthalmic Center, Sun Yat-sen University
Conditions:
Cataract
Eligibility:
All Genders
65-90 years
Phase:
NA
Brief Summary
This study is a single-center, parallel-group, randomized controlled trial with the following objectives: to compare the incidence of post-operative descemet membrane detachment (DMD) in phacoemulsifi...
Detailed Description
2.2mm incision is considered an ideal incision size in phacoemulsification. However, DMD is a common and serious complication in 2.2mm microincision phacoemulsification for hard nucleus age-related ca...
Eligibility Criteria
Inclusion
- Aged-related cataract patients between 65 and 90 years ;
- Lens nuclear opalescence grade ≥4.0 on the Lens Opacities Classification System III (LOCS III);
- Scheduled for phacoemulsification combined with intraocular lens implantation.
- The number of corneal endothelial cells \> 1500cells/mm2.
- Dilated pupil diameter ≥6mm
Exclusion
- A history of ophthalmic trauma or surgery;
- Other ophthalmic diseases such as glaucoma, uveitis, high myopia;
- Ocular factors that would make surgery challenging or dangerous, including but not limited to small pupil, shallow anterior chamber, etc.
Key Trial Info
Start Date :
July 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 22 2020
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04014699
Start Date
July 22 2019
End Date
January 22 2020
Last Update
September 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, China, 510060